银休特公司近日公布了其针对2型糖尿病成人患者研发的全闭环自动胰岛素输送系统的研究数据,结果显示该系统表现出了令人鼓舞的应用前景。
银休特公司近日公布了其针对2型糖尿病成人患者研发的全闭环自动胰岛素输送系统的研究数据,结果显示该系统表现出了令人鼓舞的应用前景。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.